Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Clinicopathological and molecular histochemical review of skull base metastasis from differentiated thyroid carcinoma.

Matsuno A, Murakami M, Hoya K, Yamada SM, Miyamoto S, Yamada S, Son JH, Nishido H, Ide F, Nagashima H, Sugaya M, Hirohata T, Mizutani A, Okinaga H, Ishii Y, Tahara S, Teramoto A, Osamura RY, Yamazaki K, Ishida Y.

Acta Histochem Cytochem. 2013 Oct 30;46(5):129-36. doi: 10.1267/ahc.13019. Epub 2013 Oct 25. Review.

2.

Skull base metastasis from follicular thyroid carcinoma -two case reports-.

Matsuno A, Katakami H, Okazaki R, Yamada S, Sasaki M, Nakaguchi H, Yamada SM, Hoya K, Murakami M, Yamazaki K, Ishida Y, Iwasaki H, Kuyama J, Kakudo K.

Neurol Med Chir (Tokyo). 2010;50(5):421-5.

3.

Follicular variant of papillary thyroid carcinoma is a unique clinical entity: a population-based study of 10,740 cases.

Yu XM, Schneider DF, Leverson G, Chen H, Sippel RS.

Thyroid. 2013 Oct;23(10):1263-8. doi: 10.1089/thy.2012.0453. Epub 2013 Sep 11.

4.
5.

Clear Cell Change in Thyroid Carcinoma: A Clinicopathologic and Molecular Study with Identification of Variable Genetic Anomalies.

Cipriani NA, Agarwal S, Dias-Santagata D, Faquin WC, Sadow PM.

Thyroid. 2017 Apr 12. doi: 10.1089/thy.2016.0631. [Epub ahead of print]

PMID:
28293986
6.

Long-term outcome of differentiated thyroid carcinoma: experience in a developing country.

Bhargav PR, Mishra A, Agarwal G, Agarwal A, Pradhan PK, Gambhir S, Verma AK, Mishra SK.

World J Surg. 2010 Jan;34(1):40-7. doi: 10.1007/s00268-009-0293-y.

PMID:
20020292
7.

Skull base metastasis from papillary thyroid carcinoma: a report of three cases.

Tunio MA, Al Asiri M, Al-Qahtani KH, Aldandan S, Riaz K, Bayoumi Y.

Int Med Case Rep J. 2015 Jun 25;8:127-31. doi: 10.2147/IMCRJ.S82792. eCollection 2015.

8.

Management considerations for differentiated thyroid carcinoma presenting as a metastasis to the skull base.

Mydlarz WK, Wu J, Aygun N, Olivi A, Carey JP, Westra WH, Tufano RP.

Laryngoscope. 2007 Jul;117(7):1146-52.

PMID:
17489069
9.

Solitary liver metastasis from follicular variant papillary thyroid carcinoma: A case report and literature review.

Djenic B, Duick D, Newell JO, Demeure MJ.

Int J Surg Case Rep. 2015;6C:146-9. doi: 10.1016/j.ijscr.2014.11.080. Epub 2014 Dec 12.

10.

Re-evaluation of histopathological factors affecting prognosis of differentiated thyroid carcinoma in an iodine-sufficient country.

Sugitani I, Toda K, Yamamoto N, Sakamoto A, Fujimoto Y.

World J Surg. 2010 Jun;34(6):1265-73. doi: 10.1007/s00268-009-0305-y.

PMID:
19953247
11.

PAX8/PPARĪ³ rearrangement in thyroid nodules predicts follicular-pattern carcinomas, in particular the encapsulated follicular variant of papillary carcinoma.

Armstrong MJ, Yang H, Yip L, Ohori NP, McCoy KL, Stang MT, Hodak SP, Nikiforova MN, Carty SE, Nikiforov YE.

Thyroid. 2014 Sep;24(9):1369-74. doi: 10.1089/thy.2014.0067. Epub 2014 Jul 16.

12.

The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma.

Machens A, Holzhausen HJ, Dralle H.

Cancer. 2005 Jun 1;103(11):2269-73.

13.

Well-differentiated thyroid carcinoma with concomitant Hashimoto's thyroiditis present with less aggressive clinical stage and low recurrence.

Huang BY, Hseuh C, Chao TC, Lin KJ, Lin JD.

Endocr Pathol. 2011 Sep;22(3):144-9. doi: 10.1007/s12022-011-9164-9.

PMID:
21647844
14.

A Bedside Risk Calculator to Preoperatively Distinguish Follicular Thyroid Carcinoma from Follicular Variant of Papillary Thyroid Carcinoma.

Englum BR, Pura J, Reed SD, Roman SA, Sosa JA, Scheri RP.

World J Surg. 2015 Dec;39(12):2928-34. doi: 10.1007/s00268-015-3192-4.

PMID:
26324158
15.

Difference between papillary and follicular thyroid carcinoma outcomes: an experience from Egyptian institution.

Aboelnaga EM, Ahmed RA.

Cancer Biol Med. 2015 Mar;12(1):53-9. doi: 10.7497/j.issn.2095-3941.2015.0005.

16.

Classification of thyroid follicular cell tumors: with special reference to borderline lesions.

Kakudo K, Bai Y, Liu Z, Li Y, Ito Y, Ozaki T.

Endocr J. 2012;59(1):1-12. Epub 2011 Sep 9. Review.

17.

Spinal metastases due to thyroid carcinoma: an analysis of 202 patients.

Kushchayeva YS, Kushchayev SV, Carroll NM, Felger EA, Links TP, Teytelboym OM, Bonichon F, Preul MC, Sonntag VK, Van Nostrand D, Burman KD, Boyle LM.

Thyroid. 2014 Oct;24(10):1488-500. doi: 10.1089/thy.2013.0633. Epub 2014 Aug 1.

PMID:
24921429
18.

Epidermal growth factor enhances proliferation, migration, and invasion of follicular and papillary thyroid cancer in vitro and in vivo.

Hoelting T, Siperstein AE, Clark OH, Duh QY.

J Clin Endocrinol Metab. 1994 Aug;79(2):401-8.

PMID:
8045955
19.

Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging.

Lang BH, Lo CY, Chan WF, Lam KY, Wan KY.

Ann Surg Oncol. 2007 Feb;14(2):730-8. Epub 2006 Nov 11.

PMID:
17103065
20.

Skull metastasis from follicular thyroid carcinoma: report of three cases and review of literature.

Shen J, Wang S, Zhao X, Shao X, Jiang X, Dai Y, Xu S, Pan X.

Int J Clin Exp Pathol. 2015 Nov 1;8(11):15285-93. eCollection 2015. Review.

Supplemental Content

Support Center